Articles

LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia

Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158
Department of Hematology/Oncology, Klinikum Rechts der Isar, Technische Universität München, München
Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158
Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158
Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158
Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158
Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158
Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA 94158
Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158
Center for Cellular and Molecular Therapeutics, The Children’s Hospital of Philadelphia, Philadelphia, PA 19104
Center for Cellular and Molecular Therapeutics, The Children’s Hospital of Philadelphia, Philadelphia, PA 19104
Center for Cellular and Molecular Therapeutics, The Children’s Hospital of Philadelphia, Philadelphia, PA 19104
Department of Pediatrics, University of Alberta, Edmonton, AB T6G 1C9, Canada
Department of Pediatrics, University of Alberta, Edmonton, AB T6G 1C9, Canada
Pediatric Hematology and Oncology, Pediatric Specialists of Virginia, Fairfax, VA 22031
OHSU Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239
Children’s of Alabama, University of Alabama Hospital, Birmingham, AL 35233
National Cancer Institute, Cairo University, Cairo, Egypt
National Cancer Institute, Cairo University, Cairo, Egypt
Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94158
Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814
Institute for Human Genetics, University of California San Francisco, San Francisco, CA 94143
Division of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia; Philadelphia, PA 19104, USA; Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine; Philadelphia, PA 19104
Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA 94158, USA; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158
Ben Towne Center for Childhood Cancer Research, Seattle Children’s Research Institute, and the Department of Pediatrics, Seattle Children’s Hospital, University of Washington, Seattle, WA, 98105
Department of Pediatrics, Benioff Children's Hospitals, University of California San Francisco, San Francisco, CA 94158, USA; Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158
Vol. 109 No. 8 (2024): August, 2024 https://doi.org/10.3324/haematol.2023.283776